Invesco Biotechnology & Genome ETF
PBE
PBE
101 hedge funds and large institutions have $77.1M invested in Invesco Biotechnology & Genome ETF in 2021 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 18 increasing their positions, 22 reducing their positions, and 8 closing their positions.
Holders
101
Holders Change
+4
Holders Change %
+4.12%
% of All Funds
1.56%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
14
Increased
18
Reduced
22
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
1 |
1
Stifel Financial
St. Louis,
Missouri
|
$1.41M |
2 |
2
Osaic Holdings
Scottsdale,
Arizona
|
$2.39M |
3 |
PA
3
PFG Advisors
Phoenix,
Arizona
|
$1.63M |
4 |
4
Goldman Sachs
New York
|
$453K |
5 |
5
Citadel Advisors
Miami,
Florida
|
$0 |